Case study: CFS/ME remission story severe patient (Treeman)
- Condition
- ME/CFS
- At worst
- Severe (mostly bedbound)
- Ill for
- Not stated
- Published
- Sep 2023
Summary
Treeman started weekly 7g subcutaneous immunoglobulin and after about three months reported his persistent shingles had cleared, his IBS improved and his IgG had risen from 4.7 to 9.1. He then caught an infection around the three-month mark lasting over two months and says he lost most of the gains, expecting up to a year to see full results.
Similar stories
-
Camici et al: IVIG treatment for Long COVID, a case report
This previously healthy 39-year-old man received a course of IVIG (intravenous immunoglobulin) for Long COVID after other multidisciplinary interventions had failed to help, though the forum thread does not reproduce the specific dose, number of infusions,…
-
Dr Chia finds enterovirus ME/CFS patients given remdesivir remain in remission (Teodora)
A long COVID patient with associated enterovirus involvement. A Paxlovid course produced remarkable reductions in pain and improved energy, but stopping it triggered a horrendous symptomatic rebound. A later molnupiravir course gave only modest benefit by…
-
Radical Rest and Beyond
The author of Encephalogirl (who signs as Michelle) treats her ME/CFS-related dysautonomia and POTS with guanfacine and low-dose Abilify (titrated from 0.5mg down to 0.25mg after migraines, then back up to 0.5mg), an increased dose of low-dose naltrexone, a…
-
Treat ME Survey Results 2
Subcutaneous immunoglobulin (SCIG), given alongside a fecal microbiota transplant, for just over a year at time of report. Before treatment he was severely unwell, underweight at 118 pounds, and unable to attend school, with comorbid POTS and mast cell…